What do you think of our new mobile-responsive site? Take our survey.
Log In / Join Now

Magazine Archives: Jan. 31 - Feb. 28, 2011

Resveratrol: Not a Silver Bullet?

Issue: February 28, 2011

GlaxoSmithKline has halted the development of SRT501, an experimental drug based on resveratrol, but that doesn't mean the pharmaceutical firm has stopped developing any medicines based on the compound. Wine Spectator assistant editor Stephanie Cain explains.


For the full article, check out the new issue of Wine Spectator, on newsstands February 1, 2011.

To continue reading this page, become a WineSpectator.com member today!

Do you have a Wine Spectator magazine subscription? Save 50% on your Online Membership right now!


Already a member?

By clicking "Log In" you agree to the Terms and Conditions of WineSpectator.com


WineRatings+ app: Download now for 300,000+ ratings.